By Katherine Robards In 2024, the field of sleep medicine saw continued growth, with advancements in technology, regulatory updates and new approaches to patient care. Over 20 FDA clearances for sleep devices highlighted ongoing innovation, while medications became a focal point with increasing use [...]

The American Academy of Sleep Medicine (AASM) is seeking public comments on the proposed revisions to the narcolepsy quality measure set, originally published in 2015, which is currently undergoing measure maintenance. The public comment period will be open for 30 days, beginning June 12, [...]

A national survey of physician practices led by the American Medical Association (AMA) is underway, and the AASM urges your cooperation with this effort. The objective of The Physician Practice Information (PPI) Survey is to gather accurate data on practice costs and the hours [...]

Private and public payers have established multiple resources and funding programs to assist providers and facilities with managing the impact of the recent cyberattack experienced by Change Healthcare, which processes 15 billion health care transactions annually. In late February, the cyberattack against Change Healthcare, [...]

The Centers for Medicare & Medicaid Services recently released the 2024 National Impact Assessment of the Centers for Medicare & Medicaid Services Quality Measures Report. The CMS impact assessments are released every three years, with this being the fifth report in the series beginning [...]

In 2023 the public health emergency related to the COVID-19 pandemic finally ended, but the Philips Respironics PAP device recall continued past its two-year anniversary. Meanwhile, the FDA took action more than 20 times to clear or expand access to sleep technology medical devices. [...]